Acne
Conference Coverage
Low-Dose Isotretinoin Tames Adult Acne
Major Finding: Sixteen weeks of low-dose isotretinoin at 5 mg/day in patients with persistent, low-grade adult acne resulted in a reduction in...
Audio
Acne and Whey Protein Supplementation
Dr. Silverberg discusses the role of whey protein supplementation in acne development in adolescent patients and the association of milk ingestion...
Original Research
Cumulative Irritation Potential and Contact Sensitization Potential of Tazarotene Foam 0.1% in 2 Phase 1 Patch Studies
We performed 2 phase 1 patch studies to evaluate tazarotene foam 0.1% for cumulative irritation potential (study A) and contact sensitization...
News
Adult Acne Woes: The Skinny Podcast
Conference Coverage
Acne Prescriptions for Topical Combination Therapy Rising
Major Finding: From 2007 to 2009, dermatologists and primary care physicians prescribed topical fixed combination treatment for 20% and 33.8% of...
News
Acne Severity Grading Scale in the Works
Conference Coverage
Derm Research Unsettles Ped's Treatment of Acne
Major Finding: Most (75.6%) neonatal and infantile acne was managed by a pediatrician, while most (67.1%) adolescent acne was managed by a...
Article
Whey Protein Precipitating Moderate to Severe Acne Flares in 5 Teenaged Athletes
Acne vulgaris has been linked to milk ingestion, both whole and skim milk. The milk fraction that promotes acne is unknown.
Article
Acneiform Eruptions Induced by Epidermal Growth Factor Receptor Inhibitors: Treatment With Oral Isotretinoin
The most common cutaneous side effects to epidermal growth factor receptor (EGFR) inhibitors are follicular or acneiform eruptions, nail disorders...
Article
Combined Oral Contraceptives for the Treatment of Acne: A Practical Guide
Many therapies exist in the arsenal of drugs available to dermatologists for the treatment of acne vulgaris. Among them, hormonal therapy stands...
Original Research
Randomized, Observer-Blind, Split-Face Study to Compare the Irritation Potential of 2 Topical Acne Formulations Over a 14-Day Treatment Period
This randomized, observer-blind, split-face study assessed the irritation potential and likelihood of continued use of clindamycin phosphate 1.2%–...